SUBSEQUENT EVENTS |
12 Months Ended |
|---|---|
Oct. 31, 2025 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | NOTE 14 – SUBSEQUENT EVENTS
Subsequent to October 31, 2025, and prior to the filing of this Annual Report on Form 10-K, the Company sold an additional 70,000 shares of its common stock for aggregate cash proceeds of $700. The shares were issued pursuant to the Company’s registered offering.
The issuance represents approximately 0.819% of the Company’s total issued and outstanding common stock as of October 31, 2025. This transaction did not have an impact on the accompanying financial statements.
In November 2025, the Company entered into an amendment to its business loan agreement originally executed in November 2024 (as described in Note 11), pursuant to which the payment of the first annual interest installment was deferred to November 13, 2026. Interest continues to accrue during the deferral period, and all other terms of the loan agreement remain unchanged. |